Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Another day of silence

<< Previous

Bullboard Posts

Next >>

Comment by emerald03on Mar 16, 2023 12:46pm

70 Views

Post# 35342807

RE:Another day of silence

Good points especially the last one. The antiviral program is useless, so many years away, probably 10 years if lucky and successful in trials, we and the company may not be alive. The petdeal seems remote, working with PRC or its companies is becoming a turnoff.
All hopes on the anti aging

<< Previous

Bullboard Posts

Next >>

Gold vs. bitcoin, where should you invest?